Novartis Pharma Stein AG (manufacturing, quality control (excluding bioanalysis), primary packaging, secondary packaging)

Ukraine

All drugs from this manufacturer

  • ILARIS

    The drug is prescribed for the treatment of periodic fever syndromes (CAP syndrome, TRAP syndrome, HID syndrome/MKD, familial Mediterranean fever), Still's disease (in adults and children), and for the symptomatic treatment of frequent attacks of gouty arthritis in adults.

    Dosage form: solution for injection

    Active substance Dosage
    canakinumab 150 mg/ml

    ATC: L04AC08